ArticleBioinformation2025
Analysis of fatal congenital anomalies among pregnant women at Saudi Arabia using ultrasonography.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between pregnant wome's health and the presence of congenital anomalies at Saudi Arabia is of interest. The total sample comprised of 100 individuals and the examinations took place in the period January 2023-January 2024. Relationships between health factors, demographic variables and foetal anomalies were assessed using Chi-square tests. With the majority of the participants being in the optimum childbearing age range, the average point of gestation at the time of the ultrasound assessment was 26.5 weeks and the average age of the women was 29.8-years old. Five major forms of congenital anomaly were observed among the 100 women examined. These were as follows: cardiac anomalies (34% of the total number of anomalies); musculoskeletal anomalies (22% of the total); central nervous system anomalies (20% of the total); gastrointestinal anomalies (15% of the total); and genitourinary anomalies (9% of the total), Just under a third (30%) of the sample reported that they had some form of adverse health condition (40% of this group had diabetes mellitus and 27% had hypertension).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.